ReviewFrontiers in pharmacology2024

Unveiling acquired resistance to anti-EGFR therapies in colorectal cancer: a long and winding road.

Alejandro Ríos-Hoyo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.